Delivery Order SPE2DB22D2005-SPE2DB25FJHJ8

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,307.80 firm-fixed-price delivery order is for the provision of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of July 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,442.50 firm fixed price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of October 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,088.50, is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. It is a firm fixed-price delivery order with an ultimate completion date of April 30, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,265.50 firm fixed price delivery order is for the supply of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The contract has an ultimate completion date of July 25, 2024. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,431.70 firm fixed-price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $9,346.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, and has an ultimate completion date of July 15, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $206,110.62 firm fixed-price delivery order is for the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with a performance period ending on November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,305.75 firm fixed-price delivery order is for the supply of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with an ultimate completion date of October 28, 2024. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,442.50, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract is a Firm Fixed Price Delivery Order with a completion date of June 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $62,964.00, is a Firm Fixed Price Delivery Order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, which appears to be a vaccine product. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. The contract does not have a set-aside designation,...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJHJ8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,296.40 firm fixed-price delivery order contract is for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of February 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 10:35 AM